Health-Related Quality of Life and Metabolic Control in Children with Type 1 Diabetes Mellitus in Bosnia and Herzegovina by Husref Tahirović et al.
Coll. Antropol. 36 (2012) 1: 117–121
Original scientific paper
Health-Related Quality of Life and Metabolic
Control in Children with Type 1 Diabetes Mellitus
in Bosnia and Herzegovina
Husref Tahirovi}1, Alma Toromanovi}2, Elnur Tahirovi}3, Hidajeta Begi}2 and James W. Varni4
1 University Clinical Centre Tuzla, Department for Research and Education, Tuzla, Bosnia and Herzegovina
2 University Clinical Centre Tuzla, Department of Paediatrics, Tuzla, Bosnia and Herzegovina
3 Clinical Center University of Sarajevo, Heart Center Sarajevo, Sarajevo, Bosnia and Herzegovina
4 Texas A&M University, College of Medicine, Department of Pediatrics, College of Architecture, Department of Landscape
Architecture and Urban Planning, Texas College Station, TX, USA
A B S T R A C T
The primary objective of the study was to examine the relationship between generic and disease-specific HRQOL
scores and metabolic control in children with Type 1 Diabetes Mellitus (T1DM). This cross-sectional study included 65
consecutive children between ages 5 and 18 years with T1DM. According to their values of glycosylated hemoglobin
(HbA1C), the children were assigned to one of two groups. In Group 1 (N=21) were the children with HbA1C values <8%
(good to moderate metabolic control) and Group 2 (N=44) were children with >8% (poor metabolic control). To evaluate
generic and disease-specific HRQOL scores in children with T1DM in relation to metabolic control, we used the
PedsQL™ 4.0 Generic Core Scales and the PedsQL™ 3.0 Diabetes Module. The patients in Group 1, by pediatric patient
self-report and parent proxy-report, had statistically better disease-specific HRQOL scores on the diabetes symptoms,
treatment barriers, treatment adherence and worry domains in comparison with Group 2. We also found significant cor-
relations between the total generic HRQOL scores and HbA1C for both parent proxy-reports’ Spearman’s coefficient of
rank correlation r=–0.257; p=0.0412 and pediatric patients’ Spearman’s coefficient of rank correlation r=–0.269; p=
0.0313. The current findings suggest that poor glycemic control in children with T1DM is associated with lower generic
and disease-specific HRQOL scores in developing and transitional countries.
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Introduction
Diabetes in children significantly affects the daily
lives of children and their parents1–4. Particularly in de-
veloping and transitional countries in which social and
health security systems are not well-developed, pediatric
diabetes can have a profound negative impact on chil-
dren and their families5.
The chronic complications of Type 1 diabetes mellitus
(T1DM) that are of concern for both parents and pediat-
ric patients with diabetes may be prevented by good
glycemic control6,7. However, achieving good blood glu-
cose control in children with diabetes is complex and
time-consuming8. It requires time, education, personal
motivation, and active ongoing communication between
patients, families and caregivers. The chronic nature of
T1DM requires consistent daily management (insulin in-
jections, testing of blood glucose levels, monitoring meals
and exercise) primarily by the caregiver and the child
with diabetes and frequent consultations with health
care providers9.
In contrast to HbA1C, which is recognized as a conven-
tional biological indicator of metabolic control in patients
with diabetes, health-related quality of life (HRQOL) fo-
cuses on the patients’ perceptions of their daily function-
ing However, often the primary interest of physicians,
health professionals and parents tends to focus on the bi-
ological and physical aspects of the disease, giving only
little importance and attention to the psychosocial con-
cerns and HRQOL of pediatric patients with diabetes10.
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Although metabolic control is an essential outcome
measure, HRQOL is increasingly recognized internation-
ally as an important overall health outcome in patients
with diabetes11,12. Some studies have shown that better me-
tabolic control was associated with higher HRQOL11,13,
while others did not find any correlation14,15.
Consequently, the primary objective of the present
study was to examine the relationship between metabolic
control and generic and diabetes-specific HRQOL scores
in children with T1DM from Bosnia and Herzegovina. To
our knowledge, there is no other study available in the
extant literature which has investigated the relationship
between generic and disease-specific HRQOL scores and
metabolic control in pediatric patients with T1DM in
Bosnia and Herzegovina. We hypothesized that better
metabolic control would be associated with higher ge-
neric and disease-specific HRQOL scores.
Methods
Demographic data
The Tuzla Canton area is situated in the northern-
-eastern part of Bosnia and Herzegovina and has an area
of 2,649 km2 with a population in 2008 of 496,380 with
106,092 children aged 0–18 years16.
Patient population
Our sample was taken from successive admissions to
the Regional Centers for the management of diabetes in
childhood at the outpatient diabetes clinic in Tuzla, Uni-
versity Clinical Center Tuzla between June and August
2008. This cross-sectional study included 65 consecutive
children between ages 5 and 18 years who had more than
6 months duration of diabetes (median of diabetes dura-
tion was 3.8 years, range: 0.65–16), with 64.6% males.
Patients were treated with an intensified insulin regi-
men (52.3%) and conventional treatment (47.7%). Dia-
betic children attend the clinic at last once every three
months. All patients and their mothers completed all the
questionnaires in the waiting room area before their
scheduled appointment. Written informed consent was
obtained from participating mothers for their child to
take part in the study. Also, informed assent was ob-
tained from each diabetic child.
Glycemic control was assessed by glycosylated hemo-
globin (HbA1C). For the study, we calculated all the mean
HbA1C values for each patient in the 12 month period
preceding the study. On average we had 3 HbA1C findings
for each patient. HbA1C was determined using the dimen-
sion clinic chemistry system HbA1C Kit from Dade Beh-
ring (Newark, DE 19714, U.S.A.). Normal values for
HbA1C were considered in the 4.4–6.3% range.
According to their HbA1C values, the children were as-
signed to one of two groups. In Group 1 (N=21) were
children with HbA1C values <8% (good to moderate met-
abolic control) and in Group 2 (N=44) were children
with HbA1C values >8% (poor metabolic control). The pa-
tients’ demographic and Clinical characteristics are pre-
sented in Table 1.
Measures and procedures
To evaluate generic and disease-specific HRQOL sco-
res in children with T1DM in relation to metabolic con-
trol, we used the previously translated unpublished Cro-
atian version of the PedsQL™ Generic Core Scales17 The
PedsQL™ 3.0 Diabetes Module18 was not available in the
Bosnian language, and was consequently translated for
the present study according to standard language valida-
tion processes. The translated version underwent a lin-
guistic validation process. In early 2008 a pilot study was
conducted on a sample of 10 respondents according to
the PedsQL™ protocol requirements to determine ac-
ceptability of the translated version.
The PedsQL™ Generic Core Scales and Diabetes Mod-
ule scales are brief and very easy to use, resulting in min-
imal missing data, and include both parent proxy-report
and child self-report with age-appropriate versions. A
user agreement was signed with the MAPI Research In-
stitute, Lyon, France, prior to using the PedsQL™ ques-
tionnaires.
The 23-item PedsQL™ 4.0 Generic Core Scales en-
compass Physical Functioning (8 items), Emotional Fun-
ctioning (5 items), Social Functioning (5 items), and
School Functioning (5 items) scales19. The PedsQL™ sca-
les are composed of parallel child self-report and parent
proxy-report formats. Child self-report and parent proxy
report includes ages 5 to 7, 8 to 12, and 13 to 18 years19.
For creating the Psychosocial Health Summary Score,
the mean is computed as the sum of the items divided by
the number of items in the Emotional, Social, and School
Functioning Scales. The total scale score is calculated as
the average of the individual item responses.
The PedsQL™ 3.0 Diabetes Module is a multidimen-
sional instrument and has five scales related to About
My Diabetes (eleven items), Treatment Barriers (four
items), Treatment Adherence (seven items), Worry (three
items), and Communication (three items) for parent proxy-










X (SD) 12.8±3.3 11.3±3.3
Range 5.0–17.5 5.1–18.0
Sex (N; %)
Boys 14 (66.7) 28 (63.6)




HbA1C (%, Median; Range) 7.3 (5.6–7.9) 8.8 (8–14.8)
-report and child self-report for ages 5 to 18 years. Child
self-report and Parent proxy-report includes ages 5 to 7
years, 8 to 12 years, and 13 to 18 years18.
A 5-point Likert scale is used across child self-report
for ages 8 to 18 years and parent proxy-report (0, never a
problem; 1, almost never a problem; 2, sometimes a prob-
lem; 3, often a problem; 4, almost always a problem). For
additional ease of use for the young child self-report
(ages 5–7 years), the Likert scale is reworded and simpli-
fied to a 3-point scale (0, not a problem; 2, sometimes a
problem; 4, a lot of a problem). Items are reverse-scored
and linearly transformed to a scale from 0 to 100 points
such that higher scores indicate better HRQOL20.
The PedsQL™ was self-administered for parents and
for children and adolescents aged 8 to 18 years and ad-
ministered by an interviewer for children aged 5 to 7
years. The estimated time to complete the PedsQL™ 3.0
Diabetes Module for children and parent was 10 to 15
minutes. Scale internal consistency reliability for the
PedsQL™ Generic Core Scales and Diabetes Module was
determined by calculating Cronbach’s coefficient alpha.
The Cronbach’s alphas for the PedsQL™ 4.0 Generic
Core Scales and the PedsQL™ 3.0 Diabetes Module in the
study ranged from 0.73 to 0.84, which is in the acceptable
range for group comparisons.
Statistical analysis
Data are presented as absolute and relative numbers,
median and interquartile range (IQR). Comparisons be-
tween groups on the PedsQL™ Diabetes Module were
made by using Mann-Whitney U-test. Spearman rank
correlation was used to examine relationships between
HbA1c values and the PedsQL™ Generic Core Scales to-
tal scale scores. Level of significance was defined with
p<0.05. In the analysis, we used the statistical package
Arcus QuickStat Biomedical version21.
Results
Table 2 contains diabetes-specific HRQOL scores for
child self-report and parent proxy-report by disease se-
verity. Higher scores indicated a better quality of life.
Across all dimensions of the PedsQL™ 3.0 Diabetes Mod-
ule, better HbA1Cvalues were associated with higher dis-
ease-specific HRQOL scores, except for the communica-
tion dimension.
Significant correlations were found between patient
self-reported PedsQL™ 4.0 Generic Core Scales total
scale score and HbA1C, Spearman’s coefficient of rank
correlation r=–0.269; p=0.0313; 95% Confidence Inter-
val for r –0.482 to –0.027), and for parent proxy-reported
PedsQL™ 4.0 Generic Core Scales total scale score and
HbA1C, Spearman’s coefficient of rank correlation r=
–0.257; p=0.0412; 95% Confidence Interval for r –0.473
to –0.012).
Discussion
The results of this study support our hypothesis that
better metabolic control is associated with better generic
and disease-specific HRQOL scores. Namely, the patients
in the good metabolic control group (Group 1), by pediat-
ric patient self-report and parent proxy-report, had sta-
tistically better disease-specific HRQOL scores in the di-
abetes symptoms, treatment barriers, treatment adher-
ence and worry domains in comparison with patients
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Children with Type 1 diabetes
pGroup 1 (N=21) (<8%) Group 2 (N=44) (>8%)
Median IQR* Median IQR*
Child self-report
Diabetes symptoms 86.4 77.2–94.1 76.2 68.2–81.8 0.0029
Treatment barriers 100 90.6–100 87.5 75–93.7 <0.0001
Treatment adherence 92.8 82.1–100 88 78.5–92.9 0.0179
Worry 92.8 70.8–100 66.6 50–91.6 0.0049
Communication 100 100–100 100 83.3–100 0.1786
Parent proxy-report
Diabetes symptoms 86.4 75–97 75 65.9–81.2 0.0008
Treatment barriers 100 85.5–100 82.2 68.2–98.5 0.0042
Treatment adherence 95.7 87.1–98.2 89.1 78.5–92.8 0.0354
Worry 91.6 66.6–100 75 50–87.7 0.0435
Communication 100 83.3–100 100 66.6–100 0.6642
*Interquartile range. Higher scores equal better HRQOL.
with poor metabolic control (Group 2). In communica-
tion domain, there were no statistically significant differ-
ences between these two groups. We also found signifi-
cant correlations between the PedsQL™ 4.0 Generic Core
Scales total scale score HbA1C by both patient self-report
and parent proxy-report. These findings are consistent
with results of studies by the Hoey and Hvidoore Study
Group members11,22, and Wagner et al.13.
It is interesting to note that in our study both chil-
dren and their mothers in both groups had very similar
responses to questions concerning HRQOL. This knowl-
edge could indicate that children with diabetes and their
mothers perceive the patients’ problems related to diabe-
tes symptoms, treatment, care and certain restrictions
imposed by the disease in the same way regardless of the
degree of metabolic control. In fact, all the mothers of
our patients are the primary caregivers of their child,
and together with their child had the same patient edu-
cation training in order to control and treat the child’s
diabetes in the home setting. Most of the mothers were
not employed, allowing more involvement in the day to
day management of their child’s disease.
In contrast to our findings, Graue et al.14 and Grey et
al.15 found that better metabolic control was not linked
to better generic HRQOL scores. In both studies the in-
vestigators used different generic HRQOL instruments,
and it is therefore difficult to directly compare their find-
ings with our findings. In addition the differences could
be because of the different ages of our patients and pa-
tients in these studies. Namely, the above mentioned
studies included only adolescents, whereas in our study
we included a broader age range.
In our opinion, the routine evaluation of generic and
disease-specific HRQOL scores should be performed at
least once every six months and the findings presented
and interpreted to both parents and child together, point-
ing out the relationship between good metabolic control
and generic and diabetes-specific HRQOL scores. In this
way, the parent and child will have the opportunity to
monitor the health outcomes of their daily efforts to
manage the child’s disease.
Limitations of the research
The present study has several limitations. First, the
study is limited by its small sample size stemming from
the low prevalence of the T1DM in Tuzla Canton, so fur-
ther reports for Bosnia and Herzegovina are needed to
confirm our findings. Second, the current study only in-
cluded mothers, which could have affected the results
and thereby limiting the conclusions that may be drawn
regarding fathers of children with T1DM, which may be
very important to consider. The inclusion of fathers in fu-
ture research would result in an alternative view of spe-
cific problems encountered by children with diabetes.
Third, the study was cross-sectional, limiting conclusions
regarding causality; a longitudinal design is required to
understand the true causal nature of the relationship be-
tween diabetes-specific problems and HRQOL scores.
Conclusions
Despite these limitations, the current findings sug-
gest that poor glycemic control in children with T1DM is
associated with lower generic and disease-specific HRQOL
scores in Bosnia and Herzegovina. In addition, the find-
ings of the study suggest that clinicians should be mind-
ful of the potential quality-of life impairments of children
with T1DM and the need for the routine evaluation of in-
dividual quality of life from the perspective of pediatric
patients and their parents. Most patients and parents
can complete the PedsQL™ 3.0 Diabetes Module scales in
less than 5 minutes, and the results can also be scored in
less than 5 minutes. This easy of use and scoring enables
patients, parents, and clinicians to discuss the results of
HbA1C testing and the results of the HRQOL evaluation
at the time of the clinic visit, with these findings then
compared to previous findings to determine positive or
negative trends in both metabolic control and HRQOL
outcomes.
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KVALITETA @IVOTA POVEZANA SA ZDRAVLJEM I METABOLI^KA KONTROLA BOLESTI KOD
DJECE OBOLJELE OD [E]ERNE BOLESTI TIPA 1 U BOSNI I HERCEGOVINI
S A @ E T A K
Istra`ivanje je provedeno s ciljem da se procijeni kvaliteta `ivota povezana sa zdravljem djece oboljele od dijabetes
melitusa tipa 1 (T1DM), u odnosu na stupanj metaboli~ke kontrole bolesti. U transverzalnoj studiji sudjelovalo je 65
djece oboljele od T1DM, u dobi od 5 do 18 godina. U odnosu na vrijednosti glikoziliranog hemoglobina (HbA1c) djeca su
podijeljena u dvije skupine. Prvu (N=21), u koju su svrstana djeca s vrijednostima HbA1c <8% (dobra do umjerena
metaboli~ka kontrola bolesti) i drugu (N=44), u koju su svrstana djeca s vrijednostima HbAc >8% (slaba metaboli~ka
kontrola). Pomo}u upitnika »PedsQLTM Generic Core Scale« i »PedsQL ™ 3,0 Diabetes Module« ispitana je kvaliteta
`ivota djece, povezana sa zdravljem. Djeca iz prve skupine prema samoizvje{}u i izvje{}u njihovih roditelja imala su
statisti~ki bolju kvalitetu `ivota povezanu sa zdravljem u domenama koje se odnose na simptome bolesti, pote{ko}e
tretmana, provo|enje tretmana i postojanje zabrinutosti u odnosu na djecu iz druge skupine. Tako|er smo na{li zna-
~ajnu povezanost izme|u ukupnog rezultata kvalitete `ivota povezanog sa zdravljem i HbA1C-a, prema procjeni ro-
ditelja (Spearmanov koeficijent korelacije rangova r=–0,257; p=0,0412) i prema procjeni djece (Spearmanov koeficijent
korelacije rangova, r=–0,269; p=0,0313). Rezultati ove studije pokazuju da je slaba kontrola glikemije u djece s T1DM
usko povezana s ni`om kvalitetom `ivota povezanom sa zdravljem u zemljama u razvoju i tranziciji.
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